Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-14

Clinical Trial Update: An Efficacy and Tolerability Study of TRAVATAN® Versus LUMIGAN® [Phase 4]

View source ↗

Summary

Phase 4 trial comparing the efficacy and tolerability of TRAVATAN (travoprost) versus LUMIGAN (bimatoprost) in glaucoma and ocular hypertension; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lumigan (bimatoprost)
  • Travatan (travoprost)

Snippet

Sponsor: Alcon Research | Conditions: Glaucoma, Ocular Hypertension | Phase 4 | Status: COMPLETED | Results posted: 2015-07-14